Cerebral ConcussionNCT05542628
Baseline Reference Values for Concussion Assessments in Football
An observational study of Cerebral Concussion, run by Federation Internationale de Football Association at 2 sites in 2 countries.
Trial summary
The primary objective is to provide normal concussion assessment references values for use in football. All National Football Associations participating in The International Football Association Board's additional permanent substitutions trial are requested to provide baseline assessment data from players within their… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cerebral Concussion
- How many people
- 2,000 participants
- Where
- 2 sitesin 2 countries
- Study dates
- 1 Jan 2021to Aug 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: The International Football Association Board (IFAB) have initiated a trial of implementing additional permanent concussion substitutions (APCS) for actual or suspected concussions. All 211 FIFA member associations (National Football Associations) are invited to participate in this trial. Participation is voluntary. The National football associations can participate with as many competitions as they wish. Competitions refer to different levels of organized leagues, as well as cup tournaments. Additionally, competitions organized by FIFA, such as the FIFA World Cup, are automatically participating in the trial.
Who may be able to join
- Male and female football players from teams in a competition participating in the concussion substitution trial.
- Players without a current suspected or confirmed concussion
Who cannot join
- Players less than 18 years of age.
Trial locations and contacts
2 sites in 2 countries.
2 sites in 2 countries
Switzerland1 site
Fèdèration Internationale de Football Association
Zurich, 8044
About this study
The primary objective is to provide normal concussion assessment references values for use in football.
All National Football Associations participating in The International Football Association Board's additional permanent substitutions trial are requested to provide baseline assessment data from players within their competitions
Read the detailed description
Concussions represent a subset of traumatic brain injury (TBI), pragmatically described as a "traumatically induced transient disturbance of brain function caused by a complex physiological process". A sports-related concussion (SRC) can result in substantially different outcomes, ranging from no detectable deficits to transient functional impairments or even life-threatening complications. While the immediate effects of most concussions are short-lived, typically resolving within days, athletes who continue to play following a concussive event may increase their risk of developing short-term, medium-term, and long-term consequences.
Diagnosing and determining the severity of a SRC immediately on- or off-field is challenging, especially because clinical signs can evolve after the mechanism of injury. Since combined injuries of the central and peripheral nervous systems are frequent, determining the locus of injury and therefore underlying explanation for symptoms is difficult and often not possible on- or off-field requiring a more focussed examination. Thus, the diagnosis and estimation of injury severity on- or off-field is a major challenge for the personnel performing an assessment. Nevertheless, an immediate, targeted assessment to support clinical decision-making is of great importance and helps to guide the management approach.
Current advice, when a player sustains a confirmed or suspected concussive injury, is to remove them from play immediately and not return to competition or unrestricted training until signs and symptoms have been managed as per relevant guidelines. Follow-up assessment of concussion incidents is recommended to include the Sport Concussion Assessment Tool 5th Edition (SCAT5). The SCAT5 is a standardized tool for use by healthcare professionals in the evaluation of individuals aged 13 years or older, who are suspected of having sustained an SRC. It comprises a neuropsychological test battery that assesses attention and memory function through 8 different domains. For further assessment of neurocognitive deficits and to inform return to play decisions, the Immediate Post-Concussion Assessment and Cognitive Testing tool version 4 (ImPACT) can also provide valuable information. The ImPACT is a computer-based neurocognitive test battery that provides an objective measure of neurocognitive functioning as an assessment aid in the management of concussed individuals aged 12-80 years.
Post-injury assessments can be compared to the player's assessment results from a non-concussed state (baseline assessment), adding more useful information to their interpretation. Unfortunately, many players do not have baseline assessments performed. Therefore, reference values from similar population groups can act as comparator to determine severity and progression of signs and/or symptoms. Reference values are reported in several sports, but values specific to football players are lacking.
The primary objective is to provide normal concussion assessment references values for use in football.
Our hypothesis is that there will be a variation of minor symptoms in non-concussed players.
Secondary objectives are to provide cumulative frequency distribution of the number of symptoms endorsed at baseline, as well as individual symptom endorsement. Additionally, we aim to provide an overview of cut-off scores and classification ranges to create a reference guide for clinicians of broadly normal and uncommon assessments. Where possible serial baseline assessments will be compared to confirm reliability.
The IFAB additional permanent substitutions trial is expected to run from January 2021 to August 2023 with potential for extension. All teams from participating competitions will be contacted and invited to participate if they have (or expect to) performed baseline assessments within the trial period. Contact information is gathered from the respective competition organisers.
The study is cross-sectional. There are no added procedures which participants have to undertake as being part of the study. The neurocognitive baseline assessments performed should already be a standard component of club practice, in line with international consensus guidelines. Normal practice is that baseline assessments are performed during the pre-season preparation period, at the time of contract commencement for a player entering a new club or one month after having been asymptomatic and medically cleared from a previous concussion injury. Other baseline demographic data will include playing position, age, sex and concussion history. The study will run for the same period as the trial. Early analysis of baseline data can be performed when all competitions have indicated their ability and willingness to participate in this study.
There is a risk of selection bias with potential higher representation of participants competitions with greater resources. To account for this, the study will accept data in any format to reduce the minor burden of participation.
Statistical analysis plan
Demographic data and baseline SCAT5 and ImPACT assessment results are summarized using descriptive statistics according to distribution to provide normal references values. Normal values will be calculated for men and women separately, and according to age, and number of previous concussions. Potential post hoc comparisons between sub-groups will be analysed using independent t-tests or Mann-Whitney U-test according to distributions, and the level of statistical significance will be set at p-value of <0.05.
Sample-size calculation is not performed due to the exploratory study design. We aim to include all available data, but a target of participant data from 1000-2000 players is expected and considered to provide a relevant impression of normal reference values. Data will be analyzed separately for specific federations given sufficient representativeness.
- Conditions
- Cerebral Concussion
- Being tested
- No intervention included
- Medical subject headings
- Brain Concussion
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No intervention includedOther
No intervention included
What is being measured
The primary outcome is the main question the study is designed to answer.
the Sport Concussion Assessment Tool 5th Edition (SCAT5)
The SCAT5 is a standardized tool for use by healthcare professionals in the evaluation of individuals 13 years old or older, who are suspected of having sustained a sports-related concussion. It comprises a neuropsychological test battery that assesses attention and memory function through 8 different domains 1) Symptom number, 2) Symptom severity, 3) Orientation, 4) Immediate memory, 5) Concentration, 6) Neurological examination, 7) Balance errors, 8) Delayed recall.
Measured: through study completion, an average of 2 years.
Secondary outcomes (1)
The Immediate Post-Concussion Assessment and Cognitive Testing tool version 4 (ImPACT)
The ImPACT is a computer-based neurocognitive test battery that provides an objective measure of neurocognitive functioning as an assessment aid in the management of concussion in individuals ages 12-80 years.
Measured: through study completion, an average of 2 years.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Sep 2022
- Study start1 Jan 2021
- Primary completion1 Jul 2024
- Study completionAug 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cerebral ConcussionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 2,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Federation Internationale de Football Association
- Sponsor type
- University, hospital or other
- Collaborators
- University of Birmingham
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05542628
- Sponsor's protocol ID
- 2
- Status last verified
- Sep 2024
- First submitted
- 7 Sep 2022
- Last updated
- 1 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Baseline Reference Values for Concussion Assessments in Football
- ClinicalTrials.gov ID
- NCT05542628
- Acronym / sponsor ID
- 2
- Conditions
- Cerebral Concussion
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 2,000 participants (estimated)
- Lead sponsor
- Federation Internationale de Football AssociationUniversity, hospital or other
- Collaborators
- University of Birmingham
- Study start
- 1 Jan 2021 (actual)
- Primary completion
- 1 Jul 2024 (actual)
- Study completion
- Aug 2025 (estimated)
- First posted
- 15 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective is to provide normal concussion assessment references values for use in football.
All National Football Associations participating in The International Football Association Board's additional permanent substitutions trial are requested to provide baseline assessment data from players within their competitions
Detailed description
Concussions represent a subset of traumatic brain injury (TBI), pragmatically described as a "traumatically induced transient disturbance of brain function caused by a complex physiological process". A sports-related concussion (SRC) can result in substantially different outcomes, ranging from no detectable deficits to transient functional impairments or even life-threatening complications. While the immediate effects of most concussions are short-lived, typically resolving within days, athletes who continue to play following a concussive event may increase their risk of developing short-term, medium-term, and long-term consequences.
Diagnosing and determining the severity of a SRC immediately on- or off-field is challenging, especially because clinical signs can evolve after the mechanism of injury. Since combined injuries of the central and peripheral nervous systems are frequent, determining the locus of injury and therefore underlying explanation for symptoms is difficult and often not possible on- or off-field requiring a more focussed examination. Thus, the diagnosis and estimation of injury severity on- or off-field is a major challenge for the personnel performing an assessment. Nevertheless, an immediate, targeted assessment to support clinical decision-making is of great importance and helps to guide the management approach.
Current advice, when a player sustains a confirmed or suspected concussive injury, is to remove them from play immediately and not return to competition or unrestricted training until signs and symptoms have been managed as per relevant guidelines. Follow-up assessment of concussion incidents is recommended to include the Sport Concussion Assessment Tool 5th Edition (SCAT5). The SCAT5 is a standardized tool for use by healthcare professionals in the evaluation of individuals aged 13 years or older, who are suspected of having sustained an SRC. It comprises a neuropsychological test battery that assesses attention and memory function through 8 different domains. For further assessment of neurocognitive deficits and to inform return to play decisions, the Immediate Post-Concussion Assessment and Cognitive Testing tool version 4 (ImPACT) can also provide valuable information. The ImPACT is a computer-based neurocognitive test battery that provides an objective measure of neurocognitive functioning as an assessment aid in the management of concussed individuals aged 12-80 years.
Post-injury assessments can be compared to the player's assessment results from a non-concussed state (baseline assessment), adding more useful information to their interpretation. Unfortunately, many players do not have baseline assessments performed. Therefore, reference values from similar population groups can act as comparator to determine severity and progression of signs and/or symptoms. Reference values are reported in several sports, but values specific to football players are lacking.
The primary objective is to provide normal concussion assessment references values for use in football.
Our hypothesis is that there will be a variation of minor symptoms in non-concussed players.
Secondary objectives are to provide cumulative frequency distribution of the number of symptoms endorsed at baseline, as well as individual symptom endorsement. Additionally, we aim to provide an overview of cut-off scores and classification ranges to create a reference guide for clinicians of broadly normal and uncommon assessments. Where possible serial baseline assessments will be compared to confirm reliability.
The IFAB additional permanent substitutions trial is expected to run from January 2021 to August 2023 with potential for extension. All teams from participating competitions will be contacted and invited to participate if they have (or expect to) performed baseline assessments within the trial period. Contact information is gathered from the respective competition organisers.
The study is cross-sectional. There are no added procedures which participants have to undertake as being part of the study. The neurocognitive baseline assessments performed should already be a standard component of club practice, in line with international consensus guidelines. Normal practice is that baseline assessments are performed during the pre-season preparation period, at the time of contract commencement for a player entering a new club or one month after having been asymptomatic and medically cleared from a previous concussion injury. Other baseline demographic data will include playing position, age, sex and concussion history. The study will run for the same period as the trial. Early analysis of baseline data can be performed when all competitions have indicated their ability and willingness to participate in this study.
There is a risk of selection bias with potential higher representation of participants competitions with greater resources. To account for this, the study will accept data in any format to reduce the minor burden of participation.
Statistical analysis plan
Demographic data and baseline SCAT5 and ImPACT assessment results are summarized using descriptive statistics according to distribution to provide normal references values. Normal values will be calculated for men and women separately, and according to age, and number of previous concussions. Potential post hoc comparisons between sub-groups will be analysed using independent t-tests or Mann-Whitney U-test according to distributions, and the level of statistical significance will be set at p-value of <0.05.
Sample-size calculation is not performed due to the exploratory study design. We aim to include all available data, but a target of participant data from 1000-2000 players is expected and considered to provide a relevant impression of normal reference values. Data will be analyzed separately for specific federations given sufficient representativeness.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- The International Football Association Board (IFAB) have initiated a trial of implementing additional permanent concussion substitutions (APCS) for actual or suspected concussions. All 211 FIFA member associations (National Football Associations) are invited to participate in this trial. Participation is voluntary. The National football associations can participate with as many competitions as they wish. Competitions refer to different levels of organized leagues, as well as cup tournaments. Additionally, competitions organized by FIFA, such as the FIFA World Cup, are automatically participating in the trial.
Key inclusion criteria (2 listed)
- Male and female football players from teams in a competition participating in the concussion substitution trial.
- Players without a current suspected or confirmed concussion
Key exclusion criteria (1 listed)
- Players less than 18 years of age.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No intervention includedNo intervention included | Other | – |
Primary outcome
the Sport Concussion Assessment Tool 5th Edition (SCAT5)
Time frame: through study completion, an average of 2 years.
The SCAT5 is a standardized tool for use by healthcare professionals in the evaluation of individuals 13 years old or older, who are suspected of having sustained a sports-related concussion. It comprises a neuropsychological test battery that assesses attention and memory function through 8 different domains 1) Symptom number, 2) Symptom severity, 3) Orientation, 4) Immediate memory, 5) Concentration, 6) Neurological examination, 7) Balance errors, 8) Delayed recall.
1 secondary outcome
The Immediate Post-Concussion Assessment and Cognitive Testing tool version 4 (ImPACT)
Time frame: through study completion, an average of 2 years.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Oct 2024.
- Individual participant dataSharing planned: No
Related trials for Cerebral Concussion
Enrolling by invitation
Improving In-hospital and Post-discharge Patient Education for Mild Traumatic Brain Injury
Concussion, Mild, Traumatic Brain Injury
Enrolling by invitation
Risk Assessment of Mild Traumatic Brain Injury in Military Training
Trauma, Brain
Not yet recruiting
Supplementary Neuromuscular Rehabilitation During Acute Concussion Recovery
Concussion (Diagnosis), Gait Abnormality
RecruitingPhase 1
Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI)
Traumatic Brain Injuries, TBI (Traumatic Brain Injury)
Not yet recruiting
Electroencephalography Markers of Brain Stimulation in Post-Concussion Patients
Patients With Persistent Post-concussion Symptoms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cerebral Concussion, run by Federation Internationale de Football Association at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 1 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Switzerland, United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
the Sport Concussion Assessment Tool 5th Edition (SCAT5) (time frame: through study completion, an average of 2 years.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2024.